Disease stage-specific atrophy markers in Alzheimer's disease
INTRODUCTION: Structural magnetic resonance imaging (MRI) often lacks diagnostic, prognostic, and monitoring value in Alzheimer's disease (AD), particularly in early disease stages. To improve its utility, we aimed to identify optimal atrophy markers for different intended uses.METHODS: We included 363 older adults; cognitively unimpaired individuals who were negative or positive for amyloid beta
